Meet Inspiring Speakers and Experts at our 3000+ Global Conference Series Events with over 1000+ Conferences, 1000+ Symposiums
and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series : World's leading Event Organizer

Back

Sara D Garduno-Diaz

Sara D Garduno-Diaz

ONO Labs, Germany

Title: Development of a plant-based dietary supplement to address life-cycle needs of the European female population

Biography

Biography: Sara D Garduno-Diaz

Abstract

Peri-natal micronutrient supplementation is commonly recommended to optimize maternal-child health outcomes in Europe. However, at no other life stage are women given practical recommendations to address their micronutrient needs. While a healthy diet remains the path of choice for nutrient intake, supplementation is often necessary to ensure adequate micronutrient intake. With the growing preference for non-synthetic ingredients and the increased market for non-animalbased
products, this work describes the process followed for the development of a plant-based multiple micronutrient supplement targeted at women at different stages of their life cycle. A list of key nutrients for inclusion was prioritized, based on the existing literature on nutrient needs for women, as well as on their most pressing wellbeing needs. This was followed by the identification and selection of qualified raw ingredient providers. The final line of products included three multiplemicronutrient
supplements meeting the following criteria: vegan, gluten-free, lactose-free, and without artificial conservatives. Each product contains specific nutrients targeting the various needs of women in their 20s, 30s and 40s; mainly hydration, skin care and hormonal dynamics, respectively. Microbiological control was carried out three-fold, once by the raw material
providers followed by double independent laboratory analysis of the end-product micronutrient supplement. This was then tested for human factor contamination, pesticides, total aerobic microbial count, total yeast count, and total mould count.Emphasis was placed on meeting product standards for the European Union, and specific requirements for the German market in food and pharma. Best practices were observed during the process to achieve multiple quality standard accreditations. In addition, organoleptic properties were adjusted in accordance to the female market demands. The results presented here reach the point of introduction of the newly developed product to the market, with acceptability and effectiveness results to be
published at a later date.